![]() |
|
|
Vol. 288, Issue 2, 550-560, February 1999
Department of Psychiatry, Uniformed Services University of the Health Sciences, Bethesda, Maryland (J.R.G.); and Laboratory of Medicinal Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland (J.R.G., F.H.E.W., K.C.R.)
| |
Abstract |
|---|
|
|
|---|
Drugs that decrease drug-maintained responding at doses that do not decrease other behaviors in animals may be suitable candidates for development as medications to treat drug abuse in humans. The present study examined whether this effect could be obtained with phentermine, a drug that has been reported to decrease cocaine intake in humans. Rhesus monkeys were trained under multiple fixed-ratio 30-response schedules of food and i.v. cocaine delivery. Phentermine was always given as a slow, i.v. infusion. Acute treatment with phentermine (0.3-10 mg/kg) decreased cocaine-maintained responding at doses that did not decrease, or decreased less, food-maintained responding for each of three unit doses of cocaine (10-100 µg/kg/injection). Subacute treatment with phentermine (3 or 5.6 mg/kg, daily) also decreased cocaine-maintained responding more than food-maintained responding. After subacute treatment was terminated, rates of cocaine-maintained responding generally recovered to levels comparable to those seen during untreated control sessions. Phentermine (0.3-3 mg/kg) did not generally increase responding associated with a very low (1 µg/kg/injection) unit dose of cocaine, suggesting that the decrease in cocaine-maintained responding at higher unit doses was not the result of a leftward shift in the cocaine unit dose-effect function. Phentermine (0.1-3 mg/kg) decreased responding maintained by 1-[2-[bis(4-fluorophenyl) methoxy]ethyl]-4-[3-phenylpropyl] piperazine (GBR 12909) (30 µg/kg/injection) at doses similar to those that decreased food-maintained responding. These results show that phentermine is effective in decreasing cocaine self-administration and suggest that it may be an effective medication for cocaine abuse.
| |
Introduction |
|---|
|
|
|---|
There
is current interest in whether pharmacological treatments can be
developed that will decrease cocaine abuse in humans. One approach to
assessing this possibility is to test potential treatments on behaviors
associated with the abuse potential of cocaine (Woolverton and Kleven,
1991
). A number of reports have shown that cocaine self-administration
can be decreased by drug treatment. However, high doses of any drug can
decrease any behavior, questioning whether these drug-induced decreases
in cocaine self-administration are behaviorally specific. Some drugs
decrease cocaine self-administration at doses that have less of an
effect on comparable rates of food-maintained responding. For example,
buprenorphine (Mello et al., 1989
), SKF 38393 (Katz and Witkin, 1992
),
GBR 12909 (Glowa et al., 1995a
), and CFT (Glowa and Wojnicki, 1996
)
decrease responding maintained by cocaine at doses that have little or
no effect on food-maintained responding. The difference in effect of
these drugs on food- and cocaine-maintained responding suggests that
self-administration was not decreased due to a nonspecific effect of
drug treatment, as a nonspecific effect would be expected to decrease
both behaviors. However, several additional interpretations of these
decreases in cocaine selfadministration remain.
If drug treatments selectively affect the potency of cocaine, they
could decrease responding maintained by peak unit doses of cocaine
without affecting food-maintained performances. Dopamine (DA)
antagonists clearly shift the unit dose-effect function for cocaine to
the right (Bergman et al., 1990
; Glowa and Wojnicki, 1996
), suggesting
that they decrease the potency of cocaine. Some (Caine and Koob, 1995
),
but not all (Glowa et al., 1995a
; Glowa and Wojnicki, 1996
) functional
DA agonists can shift the unit dose-effect function for cocaine to the
left. Further studies will be necessary to determine whether DA
agonists decrease self-administration by affecting the potency of cocaine.
Drug treatment may decrease the reinforcing effects of cocaine. A
number of procedures have been used to provide a metric of the
reinforcing effects of drugs including progressive-ratio performances,
choice situations, and the acquisition or extinction of responding
(Katz, 1990
). Lesions of specific brain structures (e.g., Caine and
Koob, 1994
), certain drugs (e.g., Roberts and Richardson, 1992
), or
access to alternative reinforcers (e.g., Nader and Woolverton, 1991
)
can decrease these measures of the reinforcing effects of cocaine.
However, few studies have determined whether drugs decrease these
measures for other events to an extent comparable to that seen for cocaine.
Drug treatment may also decrease responding that is less resistant to
change (Nevin, 1974
) more than responding maintained under other
conditions. For example, Egli et al. (1992)
showed that the same dose
of a drug decreases responding maintained by relatively low densities
of food presentation more than responding maintained by higher
densities of food presentation. Other studies have reported that doses
of several drugs decrease responding maintained by low unit doses of
cocaine more than responding maintained by high unit doses (Caine and
Koob, 1995
; Glowa et al., 1995a
; Mello and Negus, 1996
). These results
suggest that responding maintained by events with greater reinforcing
efficacies are more resistant to change. If food is a more effective
reinforcer, drug treatment could decrease cocaine self-administration
without affecting food-maintained responding.
Because few studies have studied a sufficient range of conditions to
address these interpretations, the current experiments were designed to
assess the effects of drug treatment on responding maintained by food
and several different unit doses of cocaine. Phentermine was chosen
because preliminary data suggested it could decrease cocaine-maintained
responding at doses that had less of an effect on food-maintained
responding (Glowa et al., 1997
). Phentermine is an indirect DA agonist
thought to exert its effects primarily by increasing the release of DA
(Rothman et al., 1996
). It has been given in combination with
fenfluramine (fen-phen) to decrease food intake in obese humans
(Weintraub et al., 1984
). Similarities between excessive food and drug
intake led Hitzig (1993)
to propose the use of this drug combination as
a medication for drug abuse, although there have been recent concerns
regarding its safety (Mark et al., 1997
). A case study suggested
phentermine was effective in decreasing cocaine intake in humans
(Rothman et al., 1994
). Thus, an additional purpose of the present
studies was to determine if a drug that was effective in decreasing
cocaine intake in humans could decrease cocaine-maintained responding in laboratory animals at doses that did not affect food-maintained responding.
| |
Materials and Methods |
|---|
|
|
|---|
Subjects. Eleven adult male rhesus monkeys (Macaca mulatta; nos. 31, 44, 72, 675, 872, 522, 573, 561, 941, 769, and 450), weighing 6.8 to 9.0 kg were studied. Each monkey was maintained at approximately 90% of its free-feeding weight. All monkeys had been previously trained to sit in a restraint chair (Primate Products, Redwood City, CA) during experimental sessions and had previous experience with FR schedules of food, cocaine (1-100 µg/kg/injection), and in some cases (monkey nos. 675, 872, 573, 561, 941, and 769), GBR 12909 delivery. All animals had previous experience with GBR 12909 pretreatment, and some animals had previous experience with GBR 12935 (no. 561), d-amphetamine and CFT (nos. 72, 31, and 44), or single/combined doses of phentermine and fenfluramine (nos. 675, 872, 522, and 573) pretreatment.
Apparatus.
Monkeys responded in one of four enclosed operant
chambers that were approximately 60 cm wide × 100 cm high × 90 cm deep. Each chamber was equipped with a ventilating fan, house
light, and an aluminum panel facing the monkey. The panel was equipped with two response levers (BRS/LVE, Beltsville, MD), four pairs of
lights, and a water spout. Response levers were modified by removing
the standard "paddle" and replacing it with a solid aluminum (1 × 3 × 1/4 inches) paddle, which pivoted on a pair
of pins. A downward force of about 20g (0.196 N)
on either lever produced an audible click of a feedback relay and a
response. Food (1-g banana pellets; P.J. Noyes Co., Lancaster, NH) was
delivered by a solenoid-activated food pellet dispenser (BRS/LVE) to
the receptacle immediately in front of the monkey 10 cm above the waist
plate. An indwelling i.v. jugular catheter and vascular-access port
(Access Technologies, Skokie, IL) was implanted in each monkey (Glowa et al., 1995a
,b
). A sterile infusion line connected the vascular-access port to a syringe driver. Events were programmed by a computer system
(MED-PC) and monitored on cumulative recorders.
Procedure. Animals were trained to exit the cage and to sit in a restraint chair using a pole and collar technique. They were then weighed, placed in the chamber, and the area over the port was scrubbed with betadine and alcohol. The port was accessed with a syringe fitted with a huber-point needle. Before the start of each session (after presession drug administration), the port and catheter were first flushed with saline and then filled with the drug reinforcer (cocaine or GBR 12909).
Animals were previously trained under two variants of a mult FR 30-response (FR30) food, FR30 cocaine schedule of reinforcement (Glowa et al., 1995aAcute Assessment. This experiment assessed the effects of a range of acute doses (0.3-10 mg/kg) of phentermine on responding maintained by food and different unit doses of cocaine. Acute assessments typically occurred on Tuesdays or Fridays, and control data were obtained from the four to nine intervening sessions on Thursdays. Doses of phentermine were usually tested at least twice. Responding of monkey nos. 872, 522, 675, and 573 was maintained at 10 µg/kg/injection cocaine until stable, and then the effects of phentermine were assessed. The unit dose was then increased to 30 µg/kg/injection cocaine, responding was allowed to stabilize, and the effects of phentermine were determined again. Doses higher than those necessary to almost completely decrease cocaine-maintained responding were not given to individual animals. The unit dose was then decreased to 10 µg/kg/injection cocaine, and the effects of subacute phentermine were determined (see below). After the subacute assessment, the unit dose was increased to 100 µg/kg/injection cocaine, responding was allowed to stabilize, and the effects of phentermine were determined. Monkey no.675 was not studied at 100 µg/kg/injection cocaine.
Subacute Assessment. This experiment assessed the effects of repeated daily doses of phentermine on food- and cocaine-maintained responding. Responding of monkey nos. 872, 522, 675, and 573 was maintained at 10 µg/kg/injection cocaine until stable. Control rates of responding were taken from three sessions immediately preceding the assessment of the effects of an acute dose of 5.6 mg/kg phentermine. The subacute effects of 5.6 mg/kg phentermine were then assessed for the following six to eight consecutive sessions in a manner identical to that described for acute dosing. The subacute effects of 3 mg/kg phentermine were then assessed during the following four to eight sessions. The subacute effects of saline were then assessed during the next four sessions. Finally, the acute effects of 5.6 mg/kg phentermine were re-determined in the next session.
Low Unit-Dose Assessment. Two experiments assessed the effects of phentermine when responding produced a low unit dose of cocaine. In the first experiment, responding of monkey nos. 31, 44, and 72 was maintained under a mult schedule with a unit dose of 10 µg/kg/injection cocaine until stable, then the unit dose was decreased to 1 µg/kg/injection. When rates of responding in the cocaine component had decreased compared with those during the 10 µg/kg/injection unit dose of cocaine, 3 mg/kg phentermine was given before the next session. On subsequent Tuesdays and Fridays (except for the last dose of 1 mg/kg), the effects of 1.7 mg/kg, 1 mg/kg, 0.3 mg/kg, and then 1 mg/kg phentermine were assessed. For the second experiment, responding of monkey nos. 31, 44, 522, and 72 was maintained under a mult schedule with a unit dose of 10 µg/kg/injection cocaine until stable. Then the unit dose was decreased to 1 µg/kg/injection, and an FR30 cocaine (1 µg/kg/injection), TO 20-min schedule was placed into effect (i.e., food-maintained responding was not studied, and a 20-min TO was used to keep session lengths comparable to those of the first experiment). When rates of responding had decreased compared with those in the cocaine component during the preceding baseline (10 µg/kg/injection unit dose of cocaine) conditions, 1 mg/kg phentermine was given before the next session. After two intervening sessions without infusions, the effects of 1 mg/kg were reassessed.
Assessment on GBR 12909-Maintained Responding. This experiment assessed the effects of phentermine on responding maintained by food and GBR 12909. Responding of four monkeys (nos. 561, 941, 769, and 450) was maintained under a mult FR30 food, FR30 GBR 12909 (30 µg/kg/injection) schedule until stable. The effects of a range of acute doses of phentermine were then studied. Acute assessments typically occurred on Tuesdays or Fridays, and control data were obtained from sessions on five intervening Thursdays. Doses of phentermine were tested at least twice.
Data Analysis. For each experiment, session rates of responding were calculated for each type of component (food or drug) and averaged over consecutive control sessions to provide an average rate of responding per component type, per monkey. Stability during baseline conditions was defined as no trend in rate of responding and at least three consecutive sessions when mean rates in the cocaine component varied less than 20%. Control data were typically taken from all sessions on Thursdays over the period when animals were dosed on Tuesdays and Fridays. Control data were expressed either as the mean (±S.D.) absolute response rate (resp/sec) or reinforcer deliveries, or as a mean ± coefficient of variation [(SD/mean) × 100] for percent of control data. Changes in within-session performance were characterized by the number of reinforcer deliveries to occur in each component.
Drugs. GBR12909·2HCl (1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-[3-phenylpropyl] piperazine) was synthesized by the Laboratory of Medicinal Chemistry/National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health. Cocaine was provided by the National Institute on Drug Abuse (Rockville, MD). Both drugs were dissolved in sterile water, diluted with saline, and delivered (0.75 ml/10 kg, i.v.) at a rate of 0.27 ml/sec. Unit doses were manipulated by changing the concentration (10 µg/kg/injection = 133 mg/liter). Phentermine (Sigma, St. Louis, MO) was dissolved in saline and delivered as a slow (~2 ml/min) i.v. infusion beginning 30 min before a session, for approximately 15 min (i.e., the infusion terminated about 15 min before the session began). All dose calculations were based on the salt.
| |
Results |
|---|
|
|
|---|
Acute Assessment. Control rates of responding and numbers of reinforcer deliveries for both food and cocaine when different unit doses (10, 30, and 100 µg/kg/injection) of cocaine-maintained responding are shown in Table 1. When the unit dose was 10 µg/kg/injection, rates of responding in both the food component and the cocaine component were relatively high and similar to each other. At 10 µg/kg/injection, all 40 food deliveries and almost all the cocaine deliveries were obtained. When the unit dose was 30 µg/kg/injection, the average rate of responding in the food component was similar to food-maintained rates when the unit dose was 10 µg/kg/injection, but rates of responding in the cocaine component were decreased. At 30 µg/kg/injection, almost all food deliveries were obtained, but the number of cocaine deliveries was decreased about 25%. When the unit dose was 100 µg/kg/injection, the average rate of responding in the food component was decreased compared with those at lower unit doses. This was due both to a decrease with monkey no. 872 and because the three monkeys with the lowest rates of responding were studied in this condition. At this unit dose, all food deliveries were obtained. At 100 µg/kg/injection, rates of cocaine-maintained responding were decreased compared with those maintained by lower unit doses in the same monkeys, and the number of cocaine deliveries was decreased about 50% (see Fig. 3).
|
|
|
|
Subacute Assessment. Fig. 3 shows that the effects of both acute and subacute phentermine differed across monkeys. For monkey nos. 872 and 522, the initial acute dose of phentermine decreased cocaine-maintained responding completely with little or no effect on food-maintained responding. For monkey no. 675, the initial acute dose of phentermine decreased cocaine-maintained responding completely and decreased food-maintained rates of responding about 25%. Subacute 5.6 mg/kg phentermine consistently decreased cocaine-maintained responding but had different effects on food-maintained responding in each of these animals. This subacute dose had no effect in monkey no. 522, and decreased rates of responding in monkeys no. 675 and 872. Lowering the subacute dose of phentermine to 3 mg/kg sustained the decrease in rates of cocaine-maintained responding previously observed with 5.6 mg/kg in these three monkeys. With subacute 3 mg/kg phentermine, rates of food-maintained responding were either unaffected (no. 522), similar to those seen with 5.6 mg/kg phentermine (no. 872), or increased compared with 5.6 mg/kg phentermine (no. 675). When subacute saline was given before the session instead of phentermine, rates of cocaine-maintained responding increased compared with those seen with subacute phentermine. When the effects of an acute dose of 5.6 mg/kg phentermine were redetermined after the subacute saline series, they were similar to those seen with the same acute dose given before the subacute series.
|
Low Unit-Dose Assessment. Fig. 4 (top) shows that before decreasing the unit dose of cocaine, 10 µg/kg/injection sustained high mean rates of food (2.92 resp/sec) and cocaine (3.05 resp/sec) maintained responding. This figure also shows that, when the unit dose of cocaine was decreased to 1 µg/kg/injection, rates of responding in the cocaine component decreased over the first three sessions to about 1.23 resp/sec, and rates of responding during the food component also decreased to about 2.66 resp/sec. When 3 mg/kg was given before the next session, phentermine had little effect on rates of responding in the food component but decreased rates of responding in the cocaine component. Rates of responding in both components continued to decline on days when phentermine was not given. On subsequent occasions, lower doses of phentermine increased rates of food-maintained responding, although these increases never exceeded the rate of food-maintained responding previously observed at 10 µg/kg/injection. Phentermine only decreased responding in the cocaine component. Phentermine had no effect on the number of food deliveries and decreased the number of cocaine deliveries (data not shown).
|
Assessment on GBR 12909-Maintained Responding. Under the mult FR 30 food, FR 30 GBR 12909 schedule, food-maintained high rates of responding (see Fig. 5) and all food deliveries were obtained for three of the four monkeys. One monkey (no. 450) never responded in the fourth food component, resulting in 30 food deliveries per session and lower rates of responding in the food component. GBR 12909 maintained high rates of responding (see the legend of Fig. 5) and under baseline conditions almost all GBR 12909 deliveries were obtained (range = 39.6 ± 0.9-37.6 ± 1.7).
|
| |
Discussion |
|---|
|
|
|---|
Phentermine decreased cocaine-maintained responding in the current
study. Earlier reports showed that methamphetamine decreased methamphetamine-maintained responding (Pickens et al., 1968
), and
d-amphetamine or phenmetrazine decreased cocaine-maintained responding (Wilson and Schuster, 1973
). Together, these studies suggested that drug self-administration could be decreased by drugs
that have pharmacological effects similar to those of the reinforcer.
However, the behavioral specificity of those results was not
established in the previous studies. The current study shows that
phentermine could decrease cocaine-maintained responding at doses that
do not decrease food-maintained responding in the same animal during
the same session. These findings are similar to those of recent studies
showing that GBR 12909 (Glowa et al., 1995a
, b
), CFT (Glowa and
Wojnicki, 1996
), and cocaine (Glowa and Fantegrossi, 1997
) decrease
cocaine-maintained responding at doses that have less of an effect on
food-maintained responding. These results are important because they
clearly show that cocaine-maintained responding can be affected by
doses of drugs less than those that have nonspecific effects. They also
add to a growing literature showing that drugs can affect responding
maintained by drug and food differently. However, the current study
also raises several issues with respect to interpreting those differences.
The current study does not support the possibility that
cocaine-maintained responding is decreased because phentermine affects the potency of cocaine. There is no evidence of a rightward shift in
the unit dose-effect function for cocaine, as responding maintained by
unit doses from 10 to 100 µg/kg/injection is affected by phentermine in a similar manner. Phentermine does not generally increase low rates
of responding associated with a low unit dose (1 µg/kg/injection) of
cocaine, consistent with earlier reports showing that GBR 12909 (Glowa
et al., 1995a
) and CFT (Glowa and Wojnicki, 1996
) do not increase
responding associated with a low unit dose of cocaine in the monkey.
These data suggest that phentermine does not shift the unit dose-effect
function for cocaine to the left. In contrast, because the
D3 agonist 7-OH-DPAT increases responding
associated with low unit doses of cocaine in the rat (Caine and Koob,
1995
), some drugs may produce a leftward shift. The differences between these effects raise questions as to whether drug-induced increases in
responding associated with low doses of cocaine are species-specific, occur with only certain types of DA agonists, or are unrelated to the
reinforcing effects of cocaine.
A distinctive feature of many drugs that selectively decrease
cocaine-maintained responding is that they support self-administration under other conditions. The possibility has been raised that treatment of drug self-administration with an agent that has pharmacological effects similar to those of the self-administered drug may result in a
satiation-like effect (Wilson and Schuster, 1973
). A related possibility is that response-independent drug treatment substitutes for
response-dependent drug delivery. Substitution is a functional relationship between reinforcers that is inferred when a change in the
cost (responses/unit dose) for one reinforcer results in a change in
the consumption of another reinforcer (Hursh, 1993
). Decreases in
drug-maintained responding have been well documented in studies where
concurrent access to alternative reinforcers has been arranged (Carroll
et al., 1989
; Nader and Woolverton, 1991
). Response-independent
delivery of a potentially reinforcing event may have effects on
responding similar to those of alternative reinforcement. Rachlin and
Baum (1972)
maintained responding under concurrent variable-interval
schedules of food delivery, varying several reinforcement parameters.
As expected, when the relative magnitude or frequency of food delivery
was increased in one component, responding in the alternate component
decreased. A similar effect was observed in the alternate component
when response-independent food was delivered in the other component.
Response-independent delivery of phentermine may represent a situation
in which the minimal cost (i.e., free) of drug delivery decreases
consumption of a more expensive alternative commodity (i.e., cocaine).
This interpretation is consistent with the results of Wurster et al. (1977)
, in which treatment with methadone decreased choice for heroin
while increasing choice for food. However, as few studies have directly
addressed whether more direct measures of the reinforcing effects of
drugs are decreased by drug treatment, these conclusions remain speculative.
Previous studies have noted that GBR 12909 (Glowa et al., 1995a
),
7-OH-DPAT (Caine and Koob, 1995
), and cocaine (Glowa and Fantegrossi,
1997
) decrease responding maintained by lower unit doses of cocaine
more than responding maintained by higher unit doses of cocaine. Other
studies have shown that drugs decrease responding maintained by lower
densities of food delivery more than responding maintained by higher
densities of food delivery (Egli et al., 1992
). These differences in
the effects of drug on responding maintained by the same event may
occur because responding maintained under conditions that engender more
effective reinforcement is more resistant to change than responding
maintained under conditions engendering less effective reinforcement
(Nevin, 1974
). It has been argued that higher unit doses of cocaine are
more effective reinforcers based on the results of choice (Johanson and
Schuster, 1975
), progressive-ratio (Roberts and Richardson, 1992
), and
response acquisition (Schenk et al., 1991
) procedures. In the current
research, however, phentermine decreased responding maintained by all
three unit doses of cocaine in a similar manner. These effects are
inconsistent with a resistance-to-change explanation of the selective
decreases in cocaine-maintained responding by drug treatment. Other
studies have also failed to find that reinforcement variables determine differences in drug effects. For example, Cohen (1986)
reported little
difference in the effects of several drugs on responding maintained
under random-interval schedules of food presentation that arranged
different densities of reinforcement. Currently, factors responsible
for differences in the effects of phentermine and other drugs such as
GBR 12909 on responding maintained by different unit doses of cocaine
are not known.
Phentermine also decreased responding maintained by GBR 12909, in some
cases at doses similar to those that decreased food-maintained responding. For two monkeys, food maintained higher rates of responding than GBR 12909, and higher doses of phentermine were required to
decrease food-maintained responding. For monkey no. 769, both events
maintained similar rates of responding, and phentermine had similar
effects on both performances. For monkey no. 450, GBR 12909 maintained
higher rates of responding than those maintained by food, and higher
doses of phentermine were required to decrease GBR 12909-maintained
responding. These data suggest that the rate-decreasing effects of
phentermine were influenced by control rates of responding. Although
rate of responding is not a direct measurement of the reinforcing
effects of an event, under FR schedules it may reflect certain features
of the maintaining event. For example, Powell (1969)
found that
magnitude of reinforcement was positively related to rate of responding
under FR schedules of food presentation. As the current studies did not
specifically isolate similar determinants of phentermine's effects, it
remains possible that, under different circumstances, selective
decreases in food-maintained responding could be obtained. Identifying
determinants of the selectivity of drug effects on cocaine-maintained
responding will be relevant to understanding the significance of
drug-induced decreases in drug-maintained responding.
The current results suggest that a DA releaser can produce behavioral
effects similar to those obtained with drugs that block DA reuptake
sites (e.g., GBR 12909, CFT, cocaine). While these results may suggest
that occupation of a reuptake site is not required to decrease
cocaine-maintained responding, other DA releasers (e.g.,
d-amphetamine) have been shown to interact with the uptake site (Meiergerd and Schenk, 1994
). Some pharmacological actions of
phentermine differ from those of d-amphetamine. The
additional
-methyl group of phentermine attenuates its central
stimulant and cardiovascular effects as compared with amphetamine
(Biel, 1970
). Phentermine is eliminated
(T1/2) at a slower rate, and the amount of
drug excreted unchanged is higher than that of amphetamine (Beregi et
al., 1970
). Phentermine (Rothman et al., 1996
), as well as GBR 12909, (Baumann et al., 1994
) attenuate the rise in extracellular DA in the
nucleus accumbens produced by cocaine injections. Increases in
extracellular DA have been associated with the abuse potential of drugs
(Di Chiara and Imperato, 1988
). The fact that both GBR 12909 and
phentermine can attenuate two different preclinical measures associated
with the abuse potential of cocaine, the rise in extracellular DA
induced by cocaine and the self-administration of cocaine, seems to
provide convergent data pertaining to their ability to modify the
neurobehavioral effects of cocaine.
The sustained difference in effect of phentermine on food- and cocaine-maintained responding under most of the subacute treatment conditions provided additional data showing that phentermine could affect those two behaviors differently. One monkey (no. 573) in these studies illustrated that individual differences in drug effects occur with phentermine. For this monkey, relatively low acute doses (1 mg/kg) of phentermine decreased food-maintained responding when the unit dose was 10 µg/kg/injection, and higher doses (3 mg/kg) decreased responding maintained by both events to a comparable extent. However, acute doses of 1 and 1.7 mg/kg phentermine decreased responding maintained by 30 µg/kg/injection cocaine, and the subacute dose of 3 mg/kg phentermine decreased responding maintained by 10 µg/kg/injection cocaine to a greater extent than food-maintained responding in this monkey. Thus, while this monkey appeared to be more sensitive to the rate-decreasing effects of phentermine in general, in each experiment at least one dose of phentermine decreased responding maintained by cocaine to a greater extent than food-maintained responding. Thus, phentermine produced selective effects in every monkey.
In summary, the current findings are important for several reasons.
They link recent observations that phentermine can decrease cocaine
intake in humans to decreases in cocaine-maintained responding in
animals. This observation could help validate the use of
self-administration studies to identify effective pharmacotherapies for
drug abuse (Mello and Negus, 1996
). Because phentermine may exert
effects through mechanisms distinct from those of DA reuptake
inhibitors, the range of drugs observed to produce selective decreases
on cocaine self-administration was extended by this study. The apparent efficacy of phentermine in selectively decreasing responding maintained by relatively high unit doses of cocaine may be particularly
interesting with respect to its potential as a treatment for cocaine
abuse in humans and for interpreting drug-induced decreases in
drug-maintained responding. Further research is needed to identify
factors that contribute to individual differences in the effects of
drugs on responding maintained by cocaine and the extent to which drug treatment modifies the reinforcing effects of cocaine.
| |
Footnotes |
|---|
Accepted for publication July 28, 1998.
Received for publication March 6, 1997.
1 This work was supported, in part, by a National Institute on Drug Abuse Interagency Agreement no. RA-ND-94 to 24 and by National Institute on Drug Abuse Grant RO1 DA09820 (J.R.G., Principal Investigator). Portions of the data were presented at the Society for Neuroscience Meeting, Miami, FL, 1994. All animal procedures conformed to the Guide for Care and Use of Laboratory Animals endorsed by the National Institutes of Health.
2 Clinical Psychopharmacology Section, National Institute on Drug Abuse/National Institutes of Health Addiction Research Center, Baltimore, MD.
Send reprint requests to: Dr. John R. Glowa, Professor of Pharmacology and Psychiatry, Department of Pharmacology and Therapeutics, Louisiana State University Medical School in Shreveport, 1501 Kings Highway, P.O. Box 33932, Shreveport, LA 71103-3932. E-mail: jglowa{at}lsumc.edu
| |
Abbreviations |
|---|
GBR 12909, 1-[2-[bis(4-fluorophenyl)
methoxy]ethyl]-4-[3-phenylpropyl] piperazine;
CFT, 2-
-carboxymethoxy-3-
-(4-fluorophenyl)tropane;
DA, dopamine;
FR, fixed-ratio;
mult, multiple;
TO, time-out;
LH, limited hold;
resp/sec, responses per second.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. B. Rothman, B. E. Blough, W. L. Woolverton, K. G. Anderson, S. S. Negus, N. K. Mello, B. L. Roth, and M. H. Baumann Development of a Rationally Designed, Low Abuse Potential, Biogenic Amine Releaser That Suppresses Cocaine Self-Administration J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1361 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Carelli, S. G. Ijames, and A. J. Crumling Evidence That Separate Neural Circuits in the Nucleus Accumbens Encode Cocaine Versus "Natural" (Water and Food) Reward J. Neurosci., June 1, 2000; 20(11): 4255 - 4266. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Negus, M. R. Brandt, and N. K. Mello Effects of the Long-Acting Monoamine Reuptake Inhibitor Indatraline on Cocaine Self-Administration in Rhesus Monkeys J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 60 - 69. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||